Viewing Study NCT03973918


Ignite Creation Date: 2025-12-25 @ 4:53 AM
Ignite Modification Date: 2026-03-13 @ 7:07 PM
Study NCT ID: NCT03973918
Status: TERMINATED
Last Update Posted: 2024-10-31
First Post: 2019-05-31
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None High Grade Glioma View
None BRAF V600E View
None BRAF V600K View
None Anaplastic Astrocytoma View
None Anaplastic Pleomorphic Xanthoastrocytoma View
None Gliosarcoma View
None Glioblastoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BRAF V600E/K View
None High Grade Primary Brain Tumor View
None High Grade Glioma View
None Glioblastoma View